Literature DB >> 8950683

Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production.

J N Zuckerman1.   

Abstract

No empirical data are available for the anti-HBs title required for protection against infection with the hepatitis B virus (HBV), but nonresponders to hepatitis B vaccines remain susceptible to infection. There may be an unexplained qualitative difference between hyporesponders and true nonresponders, but there is a clear association with HLA haplotypes. There is no evidence for silent infection with HBV in nonresponders.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8950683     DOI： 10.1002/(SICI)1096-9071(199612)50:4<283::AID-JMV1>3.0.CO;2-4

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


  16 in total

1.  Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.

Authors:  I Desombere; Y Gijbels; A Verwulgen; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.

Authors:  Partha P Majumder; Herman F Staats; Neeta Sarkar-Roy; Binuja Varma; Trina Ghosh; Sujit Maiti; K Narayanasamy; Carol C Whisnant; James L Stephenson; Diane K Wagener
Journal:  Hugo J       Date:  2010-03-11

3.  Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination.

Authors:  Zohreh Borzooy; Seyed Mohammad Jazayeri; Abbass Mirshafiey; Azam Khamseh; Masoud Karkhaneh Mahmoudie; Pedram Azimzadeh; Babak Geravand; Mohammad Ali Boroumand; Mina Afshar; Vahdat Poortahmasebi; Mostafa Hosseini; Adrian Streinu-Cercel
Journal:  Germs       Date:  2015-12-02

4.  Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations.

Authors:  Berran Yucesoy; Yerkebulan Talzhanov; Victor J Johnson; Nevin W Wilson; Raymond E Biagini; Wei Wang; Bonnie Frye; David N Weissman; Dori R Germolec; Michael I Luster; Michael M Barmada
Journal:  Vaccine       Date:  2013-09-26       Impact factor: 3.641

5.  Genomic correlates of variability in immune response to an oral cholera vaccine.

Authors:  Partha P Majumder; Neeta Sarkar-Roy; Herman Staats; T Ramamurthy; Sujit Maiti; Goutam Chowdhury; Carol C Whisnant; K Narayanasamy; Diane K Wagener
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

6.  A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection.

Authors:  Kejian Yang; Barbara J Whalen; Rebecca S Tirabassi; Liisa K Selin; Tatyana S Levchenko; Vladimir P Torchilin; Edward H Kislauskis; Dennis L Guberski
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

7.  B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin.

Authors:  Shikha Malhotra; Susan Kovats; Weiguo Zhang; K Mark Coggeshall
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

8.  Evaluating the cost-effectiveness of universal hepatitis B virus vaccination in Iran: a Markov model analysis.

Authors:  Ali Mohammad Mokhtari; Mohsen Barouni; Mohsen Moghadami; Jafar Hassanzadeh; Rebecca Susan Dewey; Alireza Mirahmadizadeh
Journal:  Hum Vaccin Immunother       Date:  2021-03-18       Impact factor: 3.452

9.  Homeostatic regulation of T follicular helper and antibody response to particle antigens by IL-1Ra of medullary sinus macrophage origin.

Authors:  Xinwen Lin; Trix Twelkmeyer; Danming Zhu; Li Zhang; Yang Zhao; Chao Zhang; Yoichiro Iwakura; Guangxun Meng; Zhaolin Hua; Bingyu Yan; William J Liu; Zhongguang Luo; Sitang Gong; Hairong Chen; Shuran Li; Baidong Hou; Hong Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

10.  Seroprevalence of hepatitis B virus among health care workers in Korea.

Authors:  Bo-Moon Shin; Hyeon Mi Yoo; Ae Sook Lee; Sang Keun Park
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.